The strategy of this therapy is mainly to directly deliver nano-drugs with GPX4-inhibiting function to the tumor cell or inhibit GPX4 activity by efficiently removing GSH or blocking its synthesis [54]. This evidence concerns the gene GPX4 and neoplasm.